Nuzenio

Kura Oncology Announces

Kura Oncology Announces news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Kura Oncology announces publication in Blood on ziftomenib binding profile - TipRanksTipRanks · Mon, 10 Aug 2026 16:56:39 GMTKura Oncology (KURA) Eps Diluted (TTM) - Zacks Investment ResearchZacks Investment Research · Mon, 10 Aug 2026 16:26:00 GMTKura Oncology publishes study highlighting zift... - PluangPluang · Mon, 10 Aug 2026 12:55:50 GMTKura Oncology Announces Blood Publication Detailing Discovery, Preclinical Characterization and Resistance Profile of Ziftomenib - Quiver QuantitativeQuiver Quantitative · Mon, 10 Aug 2026 12:47:00 GMTAIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:42:53 GMTMAX Power Announces $10 Million Strategic Investment at $2.50 Per Unit from Eric Sprott - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:42:50 GMTCBAK Energy to Showcase AI Data Center Backup Power Strategy and Global Capacity Roadmap at the Clean Energy Metals Virtual Investor Conference on August 27, 2026 - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:42:48 GMTSchouw & Co. share buy-back programme, week 32 2026 - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:42:47 GMT

Timeline

Mon, 10 Aug 2026 16:56:39 GMTKura Oncology announces publication in Blood on ziftomenib binding profile - TipRanks
Mon, 10 Aug 2026 16:26:00 GMTKura Oncology (KURA) Eps Diluted (TTM) - Zacks Investment Research
Mon, 10 Aug 2026 12:55:50 GMTKura Oncology publishes study highlighting zift... - Pluang
Mon, 10 Aug 2026 12:47:00 GMTKura Oncology Announces Blood Publication Detailing Discovery, Preclinical Characterization and Resistance Profile of Ziftomenib - Quiver Quantitative
Mon, 10 Aug 2026 12:42:53 GMTAIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer - The Manila Times
Mon, 10 Aug 2026 12:42:50 GMTMAX Power Announces $10 Million Strategic Investment at $2.50 Per Unit from Eric Sprott - The Manila Times

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Kura Oncology Announces.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.